chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; fever of 101'F; Second dose of Shingrix today / First dose being on 27-AUG-2020; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too short in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number 2ZN2D, expiry date unknown) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 9th October 2020, the patient received the 2nd dose of Shingrix. On 9th October 2020, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were reported as follows: On 27th August 2020, the patient received the 1st dose of Shingrix. On the date of reporting, the patient received 2nd dose of Shingrix early than the recommended schedule, which led to shortening of vaccination schedule. The reporter consented to follow up.   Follow up information was received from the physician on 20th October 2020: The patient's demographic details were updated. The patient arrived for flu shot at the time of reporting. On 9th October 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, fever. The patient was treated with ibuprofen (Advil).  The outcome of the pain in arm and fever were resolved.  It was unknown if the reporter considered the pain in arm and fever to be related to Shingrix. The VAERS details were updated. The physician misread last shingrix as 27th June 2020 instead of 27th August 2020. The vaccine was administered in an appropriate fashion with no issue.
Terrible feelings of pressure in my head  that lasted for about 4-6 weeks.  Vision loss,  ADD, auditory processing disorder,  PPD, memory loss, mood swings, no energy, brain fog, anxiety.
Started to get a rash on my legs, then the rash appeared on elbows, hands and feet. The rash is still present
Patient had shingles like blisters on her arm, neck and head, including just below the injection site of shingrix. She ran a fever, but was unaware of the exact temperature. She had an upset stomach. Patient also reported back, shoulder, and hip pain. She went to the ER and was told she had Shingles.
p/vax pt c/o of right anterior foot pain. is not able to bear full weight w/ambulation, large toe slightly puffy.rates 9 to 91/2 on scale of 1 to 10 w/10 being severe;
Pt developed small red area around shot site after injection. Area enlarged to golf-ball size with swelling the next day. Has since increased to 16x9mm area of redness and induration/warmth with a few small pinhead size papular. No fever. Pt seen by me 08/12/04 and started on Keflex for cellulitis. To follow up Monday 08/16/04.
22 y/o female received influenza vaccine injection on 10/05/2010. 5 days post vaccination patient developed wheezing, cough, and nasal congestion, which persisted for two days. Additionally, five days post vaccination patient developed hives, rash, facial swelling, trouble breathing, and wheezing. Patient was seen in the Emergency Room and was diagnosed with an allergic reaction.
Heart Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart Palpitations). At the time of the report, PALPITATIONS (Heart Palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided.  No concomitant medication was available.  Caller says that she knows of 2 other people who had heart palpitations after receiving the Moderna Covid-19 vaccine. One of them was a young girl.  Caller does not want to provide additional details on these patients.
Patient stated she felt experiencing potential angioadema and scratchy back of throat, additionally she was tachycardic and hypertensive
The RN assigned to work this clinic administered 1mL of the Moderna vaccine as opposed to 0.5mL. Attempted to reach this patient, via phone, to notify the patient and inquire about symptoms. Patient phone number listed is not correct and somewhat illegible. I made several attempts to contact by trying alternate numbers. Unable to contact patient via email as email address was not listed on the VAR.
none. Reporting vaccine error - Antigen NOT mixed in diluent. Only DILUENT given.
Information has been received from an 86 year old female patient who on 11-FEB-2011 was vaccinated with a dose of ZOSTAVAX (Merck). On 12-FEB-2011 the patient experienced weakness, severe vomiting, and diarrhea after administration. She was no longer vomiting but currently had a spastic colon, diarrhea, gas, trouble sleeping and weakness. She stated, her "whole body was in turmoil". She had been examined by a nurse on 12-FEB-2011. She would follow up with her physician on 15-FEB-2011. At the time of reporting, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
I started my menstrual period 8 days early with a much heavier than normal flow.  I have not been irregular in many years and this is the heaviest flow by far.
Nurse reported that within 24 hours the patient developed vomiting. Copies of this report have been forwarded to Merck, manufacturer of MMR II and Comvax and Aventis Pasteur, manufacturer of IPV. Additional information received 9/5/00 indicated that the patient recovered.
Sore arm one day after injection.  Itching at injjrvtion site 3-4 days after vaccination.  Itching and rash at injection site 8 days after vaccination
Swelling at site, Red and hot to touch, Pain, Lumped up, Was told to go in to be seen. Place on antibiotic, Went in on 1/2/2021. Swelling not so much now, still red and hot to touch, redness has expanded.
Severe bruising to bilateral hands (thumb and forefinger area).  Pt notes no injury.  Bruising began to develop the day after vaccination and steadily worsened over the next several days.  Bruising is still apparent 6 weeks later.
Reported moderate fever, chills, muscle aches, and fatigue for 2 days following dose 2 vaccination. Then, began complaining of chest pain. EKG abnormal and referred to Hospital for evaluation. Found to have elevated troponins and myocarditis. Then discharged home.
Severe Right shoulder pain, started hurting soon after vaccination, Has trouble with lifting arm and ADLs.
Fell from chair to floor, head fell on arm, was after shot on way to monitoring area, EMT saw and monitored in EMS area, fiance picking up patient and driving her home 10 am... vitals back to normal per EMT BP 118/62,  P 60, SP Ox 100%,R16
No adverse reaction. Vaccine was spoiled due to fridge temps too cold several days previous. Clinic did not know the temps had dropped until days later.
One week after the first dose of the Moderna COVID-19 vaccination, the injection spot on my right arm became very itchy.  Afterwards, a pinkish-red rash developed on my arm and lasted for three days.
Pain at injections site, severe headache lasting 2 days, aches in muscles and pain in entire body.  Extremely tired. In bed for 3 days with all these symptoms. Arm turned into a rash for 3 days then red bumps started, extremely itchy, red bumps went to 26, lasted 5 days then formed scabs.
This case was considered medically important. Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a nurse regarding a 12-month-old female who experienced generalized seizure, tremors and fever. At 12 months of age, the patient received a dose on 22-Dec-2003. The patient also received a dose of MMR II (measles, mumps and rubella vaccine) and Varivax (varicella virus vaccine live) vaccines on 22-Dec-2003. Medical History: Relevant medical history was not provided. Product Details: Indication for Prevnar was immunization. Product was administered on 22-Dec-2003. Dose regiment was 1 dose. Concomitant Therapy: Concomitant medications were not reported. Event Details: On 25-Dec-2003, three days post vaccination, the patient developed a fever ranging from 99.7 deg. F. to 102.6 deg. F (pyrexia). At 10:00 PM that same day, she developed tremors (tremor) and generalized seizure (convulsion). She was seen in an emergency room. The diagnosis at that time was febrile seizure, viral illness versus reaction to the immunizations. This reported was received from manufacturer. No additional information was available at the date of this report. (OMIC)
This spontaneous report was received from a 63 year old male patient reporting on himself. The patient's concurrent condition included iodine allergy. Information on medical history was not provided. On an unknown date in August 2015, the patient was vaccinated with ZOSTAVAX (lot, expiry date, route, dose number and anatomical location were not specified). Concomitant medication was not reported. Approximately in 2015 ("may be two or three weeks after"), after being vaccination with ZOSTAVAX he had been experiencing "small rashes that look more like scratches, about an inch long" (rash). The scratches resemble "zippers and bubble up [blister]". The outbreaks had been reappearing sporadically over the past four months since getting the ZOSTAVAX. He was experiencing these outbreaks on his hands, forearms, shoulders, thighs, calves and ankles (rash generalized) and he was also experiencing an outbreak today (07-JAN-2016). The patient did not recall having Chickenpox in his lifetime. The patient had sought medical attention by visiting a physician for an unspecified reason and was prescribed Mometasone Furoate cream as treatment for his symptoms. Lab diagnostics studies of routine bloodwork was performed, although their results were not provided. The patient did not currently have a physician whom he could visit regularly. The outcome of the events rash generalized and blister were reported as not recovered/not resolved at the time of reporting. There was no Product Quality Complaint (PQC) filed. The reporter did not provide the causal relationship of the events with ZOSTAVAX. Additional information is not expected as there was not consent to follow up.
Dizziness, Nausea, hx of anxiety Evaluated by Medics.  Patient left in stable condition at 9:42 A.M. Recorded by staff
her period is now 11 days late; tired; stabbing shocks in her chest (chest pain) that lasted for 3 hours; heart started to pound; she had a metallic taste in her mouth; face was numb and warm; face was numb and warm; heart rate at 160 bpm; her mouth/tongue felt itchy; her mouth/tongue felt itchy; throat felt itchy; lips numb; This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored Program. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 28Jan2021 16:00 (lot number: EL3247) at the age of 32 years old, as 1ST DOSE, SINGLE for COVID-19 immunisation. Medical history included asthma from 3 years, allergies (all her life), Chiari malformation from 10 years, vocal cord dysfunction from 3 years, Vitamin D low, constipation and Ferritin low. Concomitant medications included albuterol [salbutamol] (ALBUTEROL) taken for asthma; clarithromycin (CLARITIN) taken for allergies; iron taken for ferritin low; magnesium taken for constipation; and vitamin d [vitamin d nos] (VITAMIN D) taken for Vitamin D low; all taken from an unspecified start date and ongoing. The patient reported she had the first dose of the Pfizer COVID 19 vaccine on 28Jan2021 at 16:00PM in the left arm. About 10 minutes into her wait period (28Jan2021), her heart started to pound; her lips numb and face went numb and warm; she had metallic taste in her mouth; and her mouth/tongue and throat felt itchy. She went up to the nurse to tell her about her symptoms and they hooked her up to an O2 monitor that showed her heart rate at 160 beats per minute but her 02 was okay, it was not under 97%. She was given a generic form of Zyrtec. They monitored her for an hour and her heart pounding stopped. The metallic taste was very brief, and lips and face numbness, and mouth and throat felt itchy all resolved that same day. The next day (29Jan2021), she was tired. Then about 50 hours after the shot, in the night on the 29Jan2021 to 30Jan2021 she started getting weird stabbing shocks in her chest (chest pain) that lasted 3 hours. She would wake up with the pain and then fall back to sleep. It happened several times for a few hours then went away. Lastly, she added that she never ever misses her period but now she is two weeks late (also reported as 11 days late) and she is not pregnant. She expected her period to start on 02Feb2021. She did visit her allergist before getting the vaccine and he said none of her allergies were related to any of the ingredients in the shot. Then she saw the allergist again after the shot and the allergist didn't think she needed to be concerned as the allergist said her symptoms are not in line with an anaphylactic reaction. She is planning to receive the second dose of the vaccine on 18Feb2021. Outcome of the event 'stabbing shocks in her chest (chest pain)' was recovered on 30Jan2021. Outcome of 'her period is now 11 days late' was recovered on unspecified date. Outcome of tired was recovered on 29Jan2021, while outcome of the remaining events was recovered on 28Jan2021.
This spontaneous report as received from a registered nurse refers to a 30 years old female patient. The patient was vaccinated with (Merck) PROQUAD on 04-JAN-2012. The nurse reported that the 30 year old women had no history of previous vaccination with either MMR II or (Merck) VARIVAX at the time of the call. It was unclear at the time of the call why the (Merck) PROQUAD was administered on 04-JAN-2013. No product confusion discovered, only medication error. No adverse event reported. This is one of several reports received from the same source. Additional information has been requested.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient received Moderna vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2022 at 9:33 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 10-Feb-2022 at 9:33 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported by reporter.
Chest pain -- negative troponin. Possible perivascular stranding at aorta and celiac trunk.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 24-MAR-2015 the patient was vaccinated with an improperly stored dose (wistar ra 27-3) M-M-R II (strength: 0.5ml, lot # K015374, expiration date 18-DEC-2016, route unspecified). The total cumulative excursion time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
itchy skin, then sudden intense restlessness and hyperactivity sensation--I guess like I'm on meth (so I'm told).  can't sit still, intense need to fidget/move, can't focus, feel very tired but also like I'm overdosing on caffeine/sugar.  was randomly and for no reason at all emotional.  when trying to research this reaction, I started involuntarily crying.  feels like maybe the shot impacted the inflammation I normally have, then intensified whatever imbalance or whatever that is going on with my hormones.  started to subside at 3:30pm on 4/15/21.  now I feel exhausted.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL. Past drug history included: Lexapro, reaction(s): "Known allergies: Lexapro", notes: Known allergies: Lexapro. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment initiated with Paxlovid from 21Jul2022 to 26Jul2022. Other medication in 2 weeks product: lisinopril.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the known safety profile of the vaccine  BNT162b2, a causal relation between the reported events Covid-19, Drug ineffective and the administration of the vaccine cannot be excluded.
fatigue; temperature 102.2; weak feeling started on 2/8/21 around 3:00 symptoms still present on 2/9/21 when awakening about 8:00 am felt better around 10:00 am, when filling out this report
Patient Woke up with localized reaction. There was redness and swelling at injection site. Patient Developed 100.5F fever but additionally had symptoms of vomiting. Patient not ill prior or at time of injection. He is the second patient with these same symptoms after receiving Flu Vaccine Lot#: UJ533AA
Had received first dose of Covid vaccine and now has Covid; Had received first dose of Covid vaccine and now has Covid; This is a spontaneous report from via a non-contactable male consumer (patient, self-reported).  A male patient of unspecified age received first dose of BNT162B2 (COVID-19 Vaccine - Manufacturer Unknown, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had received first dose of Covid vaccine and now has Covid. The patient wanted to know how long he needed to wait to receive the second dose. There a was Product Complaint. Description of Product Complaint included Covid vaccine: Stated that he had received first dose of Covid vaccine and now has Covid. The patient underwent lab tests and procedures which included covid test and resulted positive for covid on an unspecified date in 2021. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a female who "within the last week" on approximately 18-SEP-2008 was vaccinated with the first dose of GARDASIL. It was reported that "right after vaccination," the patient fainted after getting GARDASIL. It was unknown if the patient sought medical attention. Additional information has been requested. This is in follow-up to report (s) previously submitted on 10/14/2008. No further information is available.
presented with R temporal/parietal/occipital HA, ear pain, R pulsatile symptom on 4/14, treated for acute otitis media with amoxicillin and eustacian tube dysfunction with long acting antihistamine and pseudoephedrine. F/u in 2 weeks but patient returned 1 week early with worsening R pulsatile tinnitus. Referred to ENT and CT angiogram completed on 4/29, MRV brain without contrast, MRI brain with and without contrast, MRI angiogram on 5/6/21 notable for cerebrovascular dural arteriovenous fistula. Patient underwent embolization procedure 5/26/21.
On approximately Day 9 after receiving the vaccine injection, my arm formed a red patch about the size and shape of a package of cigarettes.  The patch was red, swollen, and very itchy.  This last 5-7 days.
This spontaneous report was received from a registered nurse (who is reporting regarding her father) via company representative refers to a 94 year old male patient with Cardiac failure congestive. On an unknown date in NOV-2012, the patient was vaccinated with a dose of PNEUMOVAX23, (lot number, expiry date was unknown). On an unknown date in NOV-2012, the patients arm developed cellulitis, edema and was swollen. Ice pack was rendered as a treatment for the events. The events lasted for 5 days. The outcome of the events were reported as recovered. Additional information is not expected.
April 27, 2022 I was having light headedness. The next morning I started noticing swelling and tenderness in in my armpit and chest area on left side. When night time came is was progressing and with more swelling and pain and it hurts to move my left arm. I have been taking Tylenol. I have been calling Doctor's office everyday and they tell me I don't need to be seen. They just tell me to take Tylenol. I have increase pain today.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 11-FEB-2015, the patient was administered with a dose of improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This one of several reports received from the same source. Additional information has been requested.
Onset ~ 1 week post vaccination: cough, hemoptysis, left middle lobe pneumonia
"Started with fever, chills, sweating, headache, body aches and extreme fatigue about 14 hours after vaccine, symptoms subsided about 48 hours after onset."
Patient was fine at the store when he got the vaccine 4/2/21.  He didn't complain about any pain or tingling feeling.  His wife called today, 4/3/21 saying he's in a lot of pain at the site since last night.  Not red or warm to touch.  She's concerned that it was given to high up.  When I gave the injection. I used the C curb method and injected 90 degree angle to the patient.  Not sure if it's from the medicine reaction or the injection itself.  They will go to the ER to check with the doctor there.  I called PCP but office is closed on weekend.  Will follow up again on Monday.  Also patient had finished Pfizer Covid dose about a month ago, per wife.